Currently the Enterprise Value (EV) is not available for Eton Pharmaceuticals.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 2.06,
with a Debt / Equity ratio of 1.22.
2.06
1.29
1.22
-20.62
31.73
-1.3
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$1.26M
$-123.32K
31
0.51
1.02
Taxes
15K
-0.39%
Stock Price Statistics
The stock price has increased by 287.64% in the
last 52 weeks. The beta is 1.14, so Eton Pharmaceuticals's
price volatility has been higher than the market average.
1.14
287.64%
15.57
14.98
66.07
453,580
Income Statement
In the last 12 months, Eton Pharmaceuticals had revenue of 39.01M
and earned -3.82M
in profits. Earnings per share was -0.15.